The Radiologist's Approach to Assessing Cancer Risk of Thyroid Nodul…

Penn Medicine

J. Langer

ASCO® 2024 H&N Highlights: "Key Trial Updates in H&N Cancers"

2024 ASCO® Annual Meeting Insights Hub

N. Saba

Hyperprogression in Cancer Treated With Immunotherapy

Northwestern Medicine Oncology and Hematology

Y. Chae

ESMO 2024 Summary: Head & Neck Cancer Take Home Messages

2024 ESMO Annual Meeting Insights Hub

P. Bossi

ASCO® 2024 Summary: "News in Head&Neck Cancers"

2024 ASCO® Annual Meeting Insights Hub

P. Bossi

ESMO 2024 Summary: Head & Neck Cancer Highlights

2024 ESMO Annual Meeting Insights Hub

N. Saba

Year in Review: Precision Medicine

Vivek Subbiah

NOS ASCO® 2023 Review: Nasopharynx Cancer

Nebraska Oncology Society

E. Sherman

Is It Possible? Thyroglobulin as a Tumor Marker after Lobectomy for …

Keck School of Medicine of USC

T. Angell

ESMO 2024 Insights: 3-Weekly vs. Weekly Cisplatin in High-Risk HNSCC…

2024 ESMO Annual Meeting Insights Hub

M. Tahara

Tumor-Agnostic Efficacy & Safety of Selpercatinib in RET Fusion+ Sol…

UCSF School of Medicine

H. Kang

Hypercalcaemia & Hypocalcaemia

Obafemi Awolowo University

D. Soyoye

Parathyroid Disease and Tumors

Yale Cancer Center

C. Gibson

The Approach to a Patient with a Thyroid Nodule: Updating "The Bethe…

Penn Medicine

Z. Baloch

ASCO® 2023 Insights: "Expanding the Benefit - Dabrafenib/Trametinib …

Insights from 2023 ASCO® Annual Meeting

V. Subbiah

Recent Advances in Treatment of Thyroid Cancer With Precision Medici…

Jefferson Health

M. Brose

Too Much or Not Enough: When to Use Radioactive Iodine for Different…

Keck School of Medicine of USC

V. J. Bernet

ASCO® 2023 Summary: "Key H&N Cancer Studies Including FRAIL-IMMUNE &…

Insights from 2023 ASCO® Annual Meeting

P. Bossi

Thyroid Nodule Fine Needle Aspiration

Jefferson Health

J. Sheehan

Incurable HPV- Head & Neck Cancer: Panel Discussion

GRACE

J. Weiss, S. Patel, S. Sheth